-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
NEUROONE MEDICAL TECHNOLOGIES Corp annual/quarterly Depreciation, Depletion and Amortization history and growth rate from Q4 2019 to Q4 2022.
- NEUROONE MEDICAL TECHNOLOGIES Corp Depreciation, Depletion and Amortization for the quarter ending December 31, 2022 was $35.9K, a 42.6% increase year-over-year.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Depreciation, Depletion and Amortization for 2023 was $199K, a 68% increase from 2022.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Depreciation, Depletion and Amortization for 2022 was $119K, a 46.9% increase from 2021.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Depreciation, Depletion and Amortization for 2021 was $80.7K, a 69.6% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)